FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)

View source ↗

Summary

The FDA approved a supplemental application for PROTONIX DELAYED-RELEASE (pantoprazole sodium) submitted by Wyeth Pharmaceuticals LLC (Pfizer).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcers
• Erosive Esophagitis
• Gastric Ulcers
• Gastroesophageal Reflux Disease
• Peptic Ulcer Disease
• Zollinger-ellison Syndrome

Drugs mentioned

• PROTONIX DELAYED-RELEASE (Pantoprazole sodium)

Snippet

SUPPL AP for PROTONIX DELAYED-RELEASE (PANTOPRAZOLE SODIUM)